NovalGen forms partnership with HALIX B.V. to manufacture clinical materials
NovalGen, a biopharmaceutical company developing breakthrough cancer therapies and HALIX B.V., a contract development and manufacturing organisation, have agreed a strategic partnership wherein HALIX will manufacture clinical supplies for NovalGen’s therapies.